Table 1.

Studies of carbapenem-resistant Klebsiella pneumoniae in solid organ transplant recipients.

Reference	Geographic Location	Incidence of Post-Transplant CRE Infection	Median Time from Transplant to CRE Infection	Type of Infectiona	Mortality Rate
Heart Transplants
20	Brazil	16.7% (2/12)	90 days	Bacteremia: 50% Pneumonia: 50%	50% (30-day)
Lung Transplants
21b	Pittsburgh	0.4% (2/546)	218 days	Bacteremia: 100%	0% (30-day)
22	Israel	5.9% (8/136)	27 days	Pneumonia: 38% UTI: 25% Bacteremia: 25%	88% (overall)
Liver Transplants
20	Brazil	12.9% (4/31)	16 days	Bacteremia: 100% Pneumonia: 25%	25% (30-day)
21b	Pittsburgh	1.3% (8/610)	24 days	Bacteremia: 100% Pneumonia: 50%	25% (30-day)
23	New York City	8% (14/175)	12 days	Bacteremia: 86% Peritonitis: 79%	71% (overall)50% (30-day)
31b	Greece	NR (17 cases)	13 days	Bacteremia: 100%	82% (ICU mortality)
24	New York City	6.6% (20/304)	11 days	SSI/intra-abdominal: 65% Bacteremia: 55%	45% (overall)
95	Italy	8.4% (20/237)	42 days	Bacteremia: 90% Pneumonia: 30%	45% (180-day)
Kidney Transplants
25	Brazil	1.9% (21/1101)	49 days	SSI: 48% Bacteremia: 39%	42% (30-day)
20	Brazil	26.3% (5/19)	17 days	UTI: 60% Bacteremia: 60%	60% (30-day)
26	Argentina	13.3% (6/45)	36 days	UTI: 83% Bacteremia: 17%	33% (overall)
27c	New York City	1.1% (20/1852)	47 days	Bacteriuria: 100%	30% (overall)
28	New York City	2.5% (13/522)	185 days	UTI: 69% Bacteremia: 38%	46% (overall)
30	Italy	NR (8 episodes)	NR	UTI: 100% Bacteremia: 100%	0% (30-day)
Intestinal Transplants
21b	Pittsburgh	5.4% (6/112)	209 days	Bacteremia: 100%	33% (30-day)

Notes. Abbreviations: CRE, carbapenem-resistant Enterobacteriaceae; UTI: urinary tract infection; NR, not reported; ICU, intensive care unit; SSI, surgical site infection

^aThe 2 most common sites of infection are listed

^bThe study evaluated episodes of CRE bacteremia only

^cThe study evaluated episodes of CRE bacteriuria only